Sentence examples for misclassification of trials from inspiring English sources

Compared with previous meta-epidemiological studies, 1 6 8 9 10 misclassification of trials due to inadequate reporting 11 is therefore less likely to have introduced bias in our study.

All included criteria have empirical evidence that not using them in RCTs or not assessing them in systematic reviews results in bias in the estimates of treatment effect or in misclassification of trials as high or low quality.

The impact will be some misclassification of trial events resulting in an estimate of vaccine efficacy that is biased towards the null.

However, this analysis did not adjust for confounding within the individual trials, and misclassification of hyperglycemic patients may have biased the results.

To reduce the risk of misclassification of ethics reporting practices and trials' characteristics, we used a consensus between two reviewers who independently extracted information about ethical and methodological factors from the published reports.

Owing to potential selection bias and misclassification of exposure and outcome variables, trial-based estimates of MI incidence after breast cancer treatment are likely inaccurate.

Misclassification of study endpoints in randomized clinical trials of screening tests has been well documented, yet its effect on study power, type I error rate, and risk ratio estimate have not been studied in depth.

3 25262727 Several trials lacked independent adjudication of events, therefore bias in either direction cannot be excluded, including bias towards the null owing to non-differential misclassification of events or assessor bias in trials without independent adjudication.

Such effect modification could lead to nondifferential misclassification bias (trials are conducted in random order), resulting in an underestimation of the true effect that pollutant exposure has on the induction of inflammation in humans.

Our rigorous evaluation of transmission linkage reduced potential misclassification of over a quarter of seroconversion endpoints – a substantial issue for efficacy trials of interventions to reduce HIV-1 infectiousness.

In studies or trials where both sources are available, the lowest rate of misclassification of BC (2.7%) would be obtained by applying the rule that both sources need to concur for BC diagnosis.